Huoluo pills plus iguratimod for rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This trial tests a combination of a traditional Chinese medicine (Huoluo Pills) and a Western drug (iguratimod) for people with moderate rheumatoid arthritis. It aims to see if the combination works better than either treatment alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of rheumatoid arthritis (RA).
- You have moderate disease activity (DAS28 score between 2.6 and 5.1 for ESR, or between 2.3 and 4.1 for CRP).
- You are between 18 and 70 years old.
- You have not used Huoluo Pills or iguratimod in the past 4 weeks.
- If you take other RA medications (like methotrexate, leflunomide, or hydroxychloroquine), the dose must be stable for at least 12 weeks.
- You do not have certain other medical conditions (like active infections, liver or kidney problems, or recent cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a Chinese herbal formula (Bushen Quhan Zhiwang decoction) to help people with rheumatoid arthritis who also have a pattern of 'kidney deficiency and excessive cold' achieve deeper remission. It may be an option if your disease is mild to moderate and you are on a stable single medication.
This trial tests an experimental drug for people with rheumatoid arthritis who have not had success with other treatments. It aims to see if the drug can help reduce joint pain and swelling.
This trial studies whether WangBi granules help control rheumatoid arthritis symptoms when used by people already taking stable methotrexate and tofacitinib. It’s mainly for people with mild-to-moderate disease activity and specific diagnostic features.
This trial tests whether two natural plant-based medicines (diosmin and hesperidin) can reduce symptoms in people with mild to moderate rheumatoid arthritis. It compares treatment outcomes to standard care to see if these supplements help control the disease.
This study tests a new medication called AZD1163 for people with rheumatoid arthritis (RA) that hasn't responded well enough to standard treatments. It aims to see if the drug can safely reduce joint swelling and pain.
This trial tests different targeted treatments for people with rheumatoid arthritis who have tried one or two biologic or targeted synthetic drugs but still have symptoms. You need to be taking a stable dose of methotrexate.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.